8 | Analgesics (Analgesic Drugs)IBA
04/2014
-
12/2004 |
8 | Freund's AdjuvantIBA
04/2014
-
12/2002 |
5 | CarrageenanIBA
10/2011
-
12/2003 |
3 | Capsaicin (Zostrix)FDA Link
02/2012
-
07/2005 |
3 | A-317491IBA
09/2005
-
12/2002 |
2 | Biomarkers (Surrogate Marker)IBA
11/2018
-
04/2014 |
2 | Messenger RNA (mRNA)IBA
11/2018
-
01/2011 |
2 | N2- methyl- N- ((2- (4- (trifluoromethyl)phenyl)octahydrocyclopenta(c)pyrrol- 4- yl)leucinamideIBA
04/2014
-
01/2014 |
2 | CannabinoidsIBA
01/2011
-
01/2009 |
2 | A-836339IBA
01/2011
-
01/2009 |
2 | Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
02/2008
-
03/2005 |
2 | Glutamic Acid (Glutamate)FDA Link
02/2008
-
12/2004 |
2 | Vincristine (Oncovin)FDA LinkGeneric
12/2006
-
12/2004 |
2 | Naloxone (Narcan)FDA LinkGeneric
02/2006
-
09/2005 |
2 | Formaldehyde (Formol)FDA Link
09/2005
-
12/2004 |
2 | NucleotidesIBA
12/2003
-
12/2002 |
1 | CalbindinsIBA
11/2018 |
1 | ClusterinIBA
11/2018 |
1 | Cystatin CIBA
11/2018 |
1 | CreatinineIBA
11/2018 |
1 | AdenineFDA LinkGeneric
11/2018 |
1 | Extracellular Matrix ProteinsIBA
12/2017 |
1 | beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
10/2016 |
1 | Adenosine (Adenocard)FDA LinkGeneric
10/2016 |
1 | Purine NucleosidesIBA
10/2016 |
1 | Mitogen-Activated Protein Kinase 3IBA
04/2014 |
1 | N-Type Calcium Channels (N-Type Calcium Channel)IBA
09/2013 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
02/2012 |
1 | A-1048400IBA
02/2012 |
1 | Acetates (Acetic Acid Esters)FDA Link
10/2011 |
1 | 3- (3- (pyridine- 3- yl)- 1,2,4- oxadiazol- 5- yl)benzonitrileIBA
10/2011 |
1 | 5-(2-azetidinylmethoxy)-2-chloropyridineIBA
10/2011 |
1 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2011 |
1 | salicylhydroxamic acid (SHAM)IBA
01/2011 |
1 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2011 |
1 | AM 1241IBA
01/2011 |
1 | Histamine (Histamine Dihydrochloride)FDA Link
03/2010 |
1 | ZymosanIBA
03/2010 |
1 | 1- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA
03/2010 |
1 | mu Opioid Receptors (mu Opioid Receptor)IBA
01/2009 |
1 | CB2 Cannabinoid ReceptorIBA
01/2009 |
1 | cyclopropanecarboxylic acidIBA
01/2009 |
1 | AmidesIBA
01/2009 |
1 | A-889425IBA
12/2008 |
1 | PiperazineIBA
06/2008 |
1 | furanIBA
06/2008 |
1 | Lamotrigine (Lamictal)FDA LinkGeneric
06/2008 |
1 | Mexiletine (Mexitil)FDA LinkGeneric
06/2008 |
1 | Sodium Channel BlockersIBA
06/2008 |
1 | 9- dimethylamino- 3- (4- methylphenyl)- 3H- 5- thia- 1,3,6- triazafluoren- 4- oneIBA
02/2008 |
1 | 9- dimethylamino- 3- cycloheptyl- 3H- 5- thia- 1,3,6- triazafluoren- 4- oneIBA
02/2008 |
1 | 9- dimethylamino- 3- (4- ethylphenyl)- 3H- 5- thia- 1,3,6- triazafluoren- 4- oneIBA
02/2008 |
1 | A-841720IBA
02/2008 |
1 | (N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)- 2,2- dimethylpropyl)- 2- (3,4- dimethoxyphenyl)acetamide)IBA
12/2006 |
1 | Purinergic P2X7 ReceptorsIBA
12/2006 |
1 | acetamideIBA
12/2006 |
1 | Carboxylic AcidsIBA
11/2006 |
1 | LigandsIBA
11/2006 |
1 | HeptanesIBA
11/2006 |
1 | 2-phenylglycineIBA
11/2006 |
1 | Calcium Channels (Calcium Channel)IBA
11/2006 |
1 | Pregabalin (Lyrica)FDA Link
11/2006 |
1 | Gabapentin (Neurontin)FDA LinkGeneric
11/2006 |
1 | Morphine (MS Contin)FDA LinkGeneric
02/2006 |
1 | Opioid Analgesics (Opioids)IBA
09/2005 |
1 | Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
07/2005 |
1 | Urea (Carbamide)FDA LinkGeneric
07/2005 |
1 | 1- isoquinolin- 5- yl- 3- (4- trifluoromethyl- benzyl)- ureaIBA
07/2005 |
1 | Acetic Acid (Vinegar)FDA LinkGeneric
12/2004 |
1 | Insulin (Novolin)FDA Link
10/2004 |
1 | Blood Glucose (Blood Sugar)IBA
10/2004 |
1 | Neuroprotective AgentsIBA
10/2004 |
1 | Glucose (Dextrose)FDA LinkGeneric
10/2004 |